Bio Preventive Medicine (ROCO:6810) OCF Margin %: -2,839.76% (As of Dec. 2025)


ROCO:6810 Bio Preventive Medicine Corp ROCO:6810
50 GF Score
Price NT$25.10
GF Value NT$27.71
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Bio Preventive Medicine OCF Margin %?

Bio Preventive Medicine ROCO:6810 -1.76% 50 OCF Margin % is -2,839.76% as of Dec. 2025. GuruFocus rates ROCO:6810 with a GF Score™ of 50/100 and a GF Value™ of NT$27.71 (Fairly Valued). The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Bio Preventive Medicine ranks worse than 88.43% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Bio Preventive Medicine's Cash Flow from Operations for the six months ended in Dec. 2025 was NT$-45.07 Mil. Bio Preventive Medicine's Revenue for the six months ended in Dec. 2025 was NT$1.59 Mil. Therefore, Bio Preventive Medicine's OCF Margin % for the quarter that ended in Dec. 2025 was -2,839.76%.

As of today, Bio Preventive Medicine's current OCF Yield % is -6.94%.

The historical rank and industry rank for Bio Preventive Medicine's OCF Margin % or its related term are showing as below:

ROCO:6810' s OCF Margin % Range Over the Past 10 Years
Min: -5289.16   Med: -3605.63   Max: -544.46
Current: -3605.63

During the past 8 years, the highest OCF Margin % of Bio Preventive Medicine was -544.46%. The lowest was -5289.16%. And the median was -3605.63%.

ROCO:6810's OCF Margin % is ranked worse than
88.43% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs ROCO:6810: -3605.63

Bio Preventive Medicine OCF Margin % Related Terms

Bio Preventive Medicine OCF Margin % Historical Data

* Premium members only.

The historical data trend for Bio Preventive Medicine's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Preventive Medicine OCF Margin % Chart

Bio Preventive Medicine Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -5,140.83 -2,509.37 -5,289.16 -544.46 -3,605.63

Bio Preventive Medicine Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,384.63 -2,385.82 -253.49 -4,774.33 -2,839.76

ROCO:6810 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Bio Preventive Medicine's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio Preventive Medicine OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio Preventive Medicine's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Bio Preventive Medicine's OCF Margin % falls into.


ROCO:6810
50GF Score
Bio Preventive Medicine Corp ROCO:6810
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Preventive Medicine OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Bio Preventive Medicine's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-94.72/2.627
=-3,605.63 %

Bio Preventive Medicine's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-45.067/1.587
=-2,839.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -2,839.76% mean?
Bio Preventive Medicine (ROCO:6810) has a OCF Margin % of -2,839.76% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio Preventive Medicine and its competitors. According to the industry distribution chart, Bio Preventive Medicine ranks #848 out of 959 companies in the Biotechnology industry, placing it in the top 88.4%.
Is Bio Preventive Medicine's OCF Margin % too high?
Bio Preventive Medicine's current OCF Margin % is -2,839.76%. Based on the distribution chart, Bio Preventive Medicine ranks #848 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bio Preventive Medicine has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio Preventive Medicine's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bio Preventive Medicine ranks #848 out of 959 companies for OCF Margin %. This places Bio Preventive Medicine in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio Preventive Medicine and its competitors. Bio Preventive Medicine's current OCF Margin % is -2,839.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Preventive Medicine stock overvalued right now?
Based on GuruFocus' analysis, Bio Preventive Medicine (ROCO:6810) is currently considered Fairly Valued. The stock's GF Value™ is NT$27.71, compared to a current price of NT$25.10 — trading 9.4% below its estimated fair value. The current OCF Margin % is -2,839.76%. Bio Preventive Medicine's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bio Preventive Medicine (ROCO:6810), the current OCF Margin % is -2,839.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio Preventive Medicine (ROCO:6810) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Preventive Medicine stock appears to be undervalued. The current stock price of NT$25.10 is trading 9.4% below its estimated GF Value™ of NT$27.71. GuruFocus considers Bio Preventive Medicine to be Fairly Valued.

Key valuation signals for ROCO:6810:

  • OCF Margin %: -2,839.76%
  • GF Value™: NT$27.71 vs. price of NT$25.10 (9.4% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6810 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio Preventive Medicine Business Description

Address No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is a clinical-stage biotech company, focusing on the early detection and prevention of diseases specialty of those high value-added molecular diagnostic products.
50GF Score

Get the complete analysis for ROCO:6810

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$25.10
Price
NT$27.71
GF Value